MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression
- 299 Downloads
Breast cancer is one of the most common malignancies and a major cause of cancer-related mortality all over the world. A growing body of reports revealed that microRNAs play essential roles in the progression of cancers. Aberrant expression of miR-503 has been reported in several kinds of cancer. The aim of the current study was to elucidate the role of miR-503 in the pathogenesis of breast cancer. In the present study, our results suggested that miR-503 expression was markedly downregulated in breast cancer tissues and cells. Overexpression of miR-503 in breast cancer cell lines reduced cell proliferation through inducing G0/G1 cell cycle arrest by targeting CCND1. Together, our findings provide new knowledge regarding the role of miR-503 in the progression of breast cancer and indicate the role of miR-503 as a tumor suppressor microRNA (miRNA) in breast cancer.
KeywordsmiR-503 Breast cancer CCND1 Cell proliferation Cell cycle
This work was supported by Science and Technology Planning Project of Guangdong Province (2012B031800055) and National Natural Science Foundation of China (31400858). All authors designed the study together, performed the experiment together, analyzed the data, and wrote the paper; all authors approved the final manuscript.
Conflicts of interest
- 1.Siegel R, Desantis C, Jemal A. Colorectal cancer statistics. CA: Cancer J Clin. 2014;64:104–17.Google Scholar
- 2.Park YH, Lee SJ, Jung HA, Kim SM, Kim MJ, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH. Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: single institutional experience in Korea. Breast (Edinburgh, Scotland) 2015.Google Scholar
- 21.Valinezhad Orang A, Safaralizadeh R. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. 2014;2014:970607.Google Scholar
- 22.Vidaurre S, Fitzpatrick C, Burzio VA, Briones M, Villota C, Villegas J, et al. Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy. J Biol Chem. 2014;289:27182–98.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Humphries B, Yang C. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget 2015.Google Scholar